More on ARTL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.63 |
|
|||
| Open | $5.63 | ||||
| 52 Wk High | $6.22 | ||||
| 52 Wk Low | $2.74 | ||||
| Day High | $5.63 | ||||
| Day Low | $5.63 | ||||
| P/E | N/A | ||||
| EPS | $-0.21 | ||||
| Volume | 51 | ||||
- Form 8-K ARTELO BIOSCIENCES, INC. For: Aug 26
- Artelo Biosciences executes 1-for-9 reverse stock split
- Artelo Biosciences Announces Reverse Stock Split
- Form 10-Q/A ARTELO BIOSCIENCES, INC. For: Jun 30
- Artelo Biosciences wins Japan patent allowance for ART27.13
- Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
- Artelo Biosciences gets U.S. patent allowance for ART27.13 drug
- Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
- Form SCHEDULE 13G/A ARTELO BIOSCIENCES, INC. Filed by: ARMISTICE CAPITAL, LLC
- Form SCHEDULE 13G/A ARTELO BIOSCIENCES, INC. Filed by: INTRACOASTAL CAPITAL, LLC
Entities mentioned with ARTL
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- S1 | View Related Stories »
- 13G | View Related Stories »
- Show More...
